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Reply to the Editor:
We read with interest the letter by Filosso
from the University of Torino. When the
patient came to our department, we had
questions similar to those that Filosso
posed.
In Japan, scintigraphy with indium In-
111 pentetreotide (OctreoScan) is still only
available for research purposes, not for
clinical use. This is one of the reasons why
we did not perform the scan before 2001,
nor did we after the operation.
As Filosso mentioned, it is thought
that bronchial carcinoid producing adre-
nocorticotropic hormone is aggressive.1
However, our patient showed a different
clinical course, as we reported. More
than 5 years passed between the onset of
symptoms and her operation. Despite her
long follow-up duration, no change in
the size of mediastinal nodes was de-
tected by serial examination until 2001.
This may be the reason that her physician
hesitated to consult us. In addition, the
levels of adrenocorticotropic hormone
and cortisol had not become worse during
her course.
With regard to the use of a mediastino-
scope, we also believe that this procedure is
a useful method to localize and diagnose a
tumor. However, with this procedure, it is
sometimes difficult to perform en bloc re-
moval of the whole tumor. We were also
afraid that piece by piece removal might
cause an intraoperative crisis of Cushing
syndrome. In addition, our previous stud-
ies2,3 showed that removal of lymph nodes
could be completed under thoracoscopic
surgery. Our data revealed that only 2% of
lymph nodes in weight could not be re-
moved when performing sequential thora-
cotomy just after thoracoscopic surgery.
Regarding the region of pretracheal and
paratracheal lymph nodes, no residual
lymph nodes were detected in our studies.
So in our case, we chose thoracoscopic
surgery.
As mentioned by Filosso, we also be-
lieve that any pulmonary masses should be
investigated in case of suspected ectopic
adrenocorticotropic hormone production.
However, we did not detect any tiny le-
sions in either lung on thin-sliced com-
puted tomographic images. In such case,
should we perform bilateral thoracotomy?
We informed our patient, and she chose
thoracoscopic resection. We also told her
and her family about the possible need for
further surgery should a new lung mass
shadow develop.
Octreotide is also a good alternative
option for adjuvant therapy in cases of
stage III carcinoid tumor after surgery to
prevent recurrence.4,5 Before our pa-
tient’s operation, she received octreotide
treatment for about 1 year. She refused to
continue the treatment, however, because
of pain caused by subcutaneous injection.
Now 2 years have passed since her oper-
ation. She is doing well without any signs
of recurrence; the values of hormones are
within normal ranges, and no abnormal
mass has been detected by whole-body
screening.
Finally, we appreciate Filosso’s advice.
He advised us to implement a follow-up
plan including OctreoScan scintigraphy
and possible octreotide treatment. Consid-
ering his advice, we will discuss her adju-
vant therapy and follow-up plan with her
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Spiral pattern: Universe, normal
heart, and complex congenital
defects
To the Editor:
In the fascinating article “Basic Science
Review: The Helix and the Heart”1 in a
recent issue of Journal, Gerald Buckberg,
supported by the anatomic studies of Tor-
rent-Guasp and colleagues,2 illustrated the
spiral anatomy of the muscle bands and the
helicoid shape of the myocardium. On the
basis of recent observations on embryology
and genetics, we have reached similar con-
clusions regarding the spiral pattern of the
heart morphology in complex congenital
defects.3
The normal heart has a clockwise spiral
pattern of the outflow tracts and of the great
arteries. The helicoid 3-dimensional move-
ment driving to this condition, genetically
determined in subjects with situs solitus,
appears with the dextroventricular loop
(right ventricle to the right, left ventricle to
the left),4 progresses with the looping (an-
terior rotation of the right ventricle, poste-
rior rotation of the left ventricle), and fin-
ishes with the spiral septations of the
outflow tracts and the great arteries.5 Be-
cause the dextroventricular loop is the first
recognized sign of asymmetry and lateral-
ization of the body organs,4 the clockwise
spiralization of the heart should be consid-
ered a specific pattern of chirality in verte-
brates. In subjects with situs inversus, an
incompletely understood genetic mecha-
nism6 is responsible for a “mirror image”
anatomy of the heart, with counterclock-
wise shape of the outflow tracts and great
arteries. This condition appears with a
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levoventricular loop (right ventricle to the
left, left ventricle to the right), progresses
with an inverted looping, and finishes with
an inverted spiral septation of the outflow
tracts and the great arteries. Therefore the
spiral shape of the heart is the consequence
of an asymmetric formation, and it derives
from coordinated developmental mecha-
nisms involving, in a 3-dimensional fash-
ion, the segments of ventricles and great
arteries. In contrast to patients with situs
ambiguus the genetically determined
anomalies of lateralization6 cause, at the
cardiac level, an interruption of the heli-
coid pattern consisting in isomerism of the
atria, random ventricular loop, and trans-
position of the great arteries. This is par-
ticularly frequent in patients with right
isomerism (asplenia syndrome).3 To sum-
marize these observations, the helicoid
shape of the heart is genetically deter-
mined and may be clockwise in situs
solitus, counterclockwise in situs inver-
sus, and absent or interrupted in situs
ambiguus.
The helicoid shape of the heart is inter-
rupted in other types of complex congenital
heart defects. In congenitally corrected
transposition of the great arteries [S,L,L],
there is situs solitus of the atria, but with a
levoventricular loop and a transposition of
the great arteries. The resulting anatomic
pattern is neither clockwise nor counter-
clockwise. In this complex malformation,
the helicoid shape of the heart is inverted at
ventricular level and interrupted at the level
of the great arteries. In complete transpo-
sition of the great arteries [S,D,D], despite
the presence of situs solitus of the atria and
dextroventricular loop, the parallel position
of the great arteries shows the interruption
of the spiral pattern of the heart. Experi-
mental research on animals,7 clinical stud-
ies on familial recurrence,8 and results of
human genetic mutations9 suggest that
both these complex cardiac defects, con-
genitally corrected transposition of the
great arteries and complete transposition
of great arteries, could be included in the
pathogenetic group of the defects of lat-
eralization.
In conclusion, the concept of a spiral
pattern of the heart may have important
implications not only for the fields of myo-
cardial morphology, pathophysiology, and
cardiac surgery1 but also for our under-
standing of the segmental morphogenetic
mechanisms of some complex congenital
heart defects. There is no doubt that the
helicoid shape of the heart recalls some
structural aspects of plants and animals,
and also patterns observed in the micro-
cosm and macrocosm alike.1,3 The physic
and genetic causes of these similarities will
advance our efforts toward comprehension,
if we will be able to maintain the attitude of
the student.1
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Cardiac transplantation in prisoners
To the Editor:
I have just finished reading Drs McKneal-
ly’s and Sade’s thoughtful editorial regard-
ing cardiac transplantation in prisoners. A
number of years ago I attended a transplant
ethics conference. In the course of the
meeting a case was presented of a young
prisoner. He was suffering from heart fail-
ure and the issue arose as to whether he
should be offered cardiac transplantation.
Although I was only a conference attendee,
the moderator recognized that I was the
surgical director of our cardiac transplant
program. The moderator asked me if such a
patient would be offered cardiac transplan-
tation at our institution. I stated that one of
the cardiac transplant selection criteria was
a stable psychosocial background. I did not
believe that incarceration fulfilled that cri-
terion. Thus, I informed the group that we
would not offer such a patient a cardiac
transplant.
Although I understand the ethical right
that a prisoner has to this therapy and I am
sensitive to the cost that such care imposes
on the prison system, I have a more prac-
tical concern about offering transplantation
to prisoners. Nelson Mandela aside, can we
rely upon these individuals to participate in
the close posttransplant follow-up neces-
sary to ensure the success of this treatment?
Can these patients be trusted to comply
with their immunosuppressive drug regi-
men? I suspect that the answer to these
questions is “no.” The donor heart is a
precious commodity and as such should
be offered only to patients in whom there
is a reasonable chance for long-term sur-
vival.
Thank you for providing us with a start-
ing point for ongoing discussion of this
very relevant dilemma.
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